Key Takeaways
- Robinhood CEO Vlad Tenev maintains that publicly traded companies lack authority to prohibit third-party tokens representing their shares when existing shareholder rights remain unaffected.
- The controversy ignited when AMC Entertainment CEO Adam Aron branded Robinhood’s AMC Stock Token a “quasi-fake market” and warned of potential SEC involvement.
- Dan Gallagher, Robinhood’s chief legal officer, responded aggressively, challenging AMC to “send your lawyers.”
- DEX trading volume for tokenized stocks reached $4.3 billion in the past week, with Robinhood commanding 66.3% market dominance.
- The upcoming CLARITY Act vote, anticipated around September 15, represents a critical regulatory milestone.
On September 11, 2026, Robinhood CEO Vlad Tenev published a comprehensive statement on X, establishing clear parameters for when public corporations can legitimately prevent the creation of stock tokens linked to their traded securities.
Tenev’s position is unambiguous: when a token preserves existing shareholder rights, avoids replacing the company’s official share registry, and imposes no additional corporate obligations, issuer approval is unnecessary.
This declaration followed a week of intense public confrontation with AMC Entertainment CEO Adam Aron, who on September 3 described Robinhood’s AMC Stock Token as “contemptible” and “outrageous.”
Aron emphasized that AMC maintained zero association with the product and warned of potential SEC escalation. He characterized the offering as a “quasi-fake market” operating through a Jersey-based entity and insisted Robinhood “cease and desist.”
Dan Gallagher, Robinhood’s chief legal officer and former SEC commissioner, issued a defiant response. “We know a little something about U.S. securities laws,” Gallagher declared on X, “and will not ‘DECIST.’ Send your lawyers and we’ll educate them.”
Tenev reinforced this stance: “We stand behind Stock Tokens.”
Understanding Token Ownership Structure
Robinhood’s Stock Tokens represent tokenized debt instruments issued through Robinhood Assets (Jersey) Limited. Every token maintains 1:1 backing with actual shares, providing holders with dividend exposure.
Nevertheless, token owners lack legal or beneficial ownership claims against the underlying issuer and generally possess no voting privileges. These tokens operate outside U.S. Securities Act registration requirements and are unavailable to U.S. persons.
Tenev acknowledges specific boundaries. When a token modifies fundamental share rights, substitutes the official registry, or creates additional responsibilities for the issuer or transfer agent, he concedes the company deserves participation.
Robinhood maintains its offering crosses none of these thresholds. The platform references comparable precedents in established markets, including options contracts, unsponsored American depositary receipts, and structured instruments that reference public equities without granting issuers product oversight.
Trading Volume Analysis and Alternative Approaches
Last week witnessed $4.3 billion in tokenized-stock DEX trading volume. September 4ācoinciding with the peak of the AMC controversyāestablished a single-day milestone of $1 billion.
Robinhood captured 66.3% of this activity, approximately $2.87 billion. Market analysts monitoring HOOD identify the Stock Token portfolio as a primary growth catalyst, establishing a $165 price target for the equity.
Alternative frameworks from Securitize and Coinbase mandate issuer participation. Robinhood’s independent wrapper structure eliminates this requirement, enabling the platform to offer 190+ securities without individual negotiations.
Coinbase has formally notified the SEC that requiring issuer consent for third-party tokenization would grant issuers veto authority they lack in secondary trading markets. Transfer-agent organizations have countered by requesting the SEC restrict regulatory relief exclusively to issuer-sponsored tokens.
With the CLARITY Act vote anticipated around September 15, the tokenized equities sector approaches its next significant regulatory crossroads.





